InMode Ltd. (INMD)
| Market Cap | 2.83B |
| Revenue (ttm) | 231.19M |
| Net Income (ttm) | 95.24M |
| Shares Out | 38.19M |
| EPS (ttm) | 1.16 |
| PE Ratio | 63.92 |
| Forward PE | 25.64 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 14 |
| Last Price | $74.08 |
| Previous Close | $68.79 |
| Change ($) | 5.29 |
| Change (%) | 7.69% |
| Day's Open | 70.00 |
| Day's Range | 69.52 - 74.31 |
| Day's Volume | 894,568 |
| 52-Week Range | 24.76 - 92.38 |
Shareholders of Builders FirstSource Inc (BLDR, Financial), Deckers Outdoor Corp (DECK, Financial) and InMode Ltd (INMD, Financial) saw the value of their assets increase significantly in recent years, ...
YOKNEAM, Israel, May 5, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its f...
InMode's (INMD) Morpheus8 Platform and Morpheus8 Body that use RF fractional technology are expected to have continued to contribute to the company's Q1 top line.
YOKNEAM, Israel, April 12, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results...
YOKNEAM, Israel, March 30, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced Mr.
Every Friday, at 3 p.m. ET, Ritholtz Wealth Management CEO Josh Brown and Benzinga CEO Jason Raznick host "The Boiler Room," a Clubhouse audio chat where listeners can pitch their favorite stock.
YOKNEAM, Israel, March 16, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has filed a complaint with the United States International Trade...
Those looking for growth stocks to watch are always trying to discover top stocks making bullish moves amid rising profit estimates. Here are some ideas.
InMode also held up above its fast-climbing 50-day moving average, a good sign for now. The post Growth Stocks Take A Shellacking; Is It Time To Lock In Profits In InMode, 360 DigiTech?
InMode (INMD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
InMode (INMD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down ...
The best stocks to buy and watch often show increasing fund ownership. That's why Celsius Holdings, InMode and Rio Tinto should be on your radar.
Shares of InMode (NASDAQ:INMD) fell 0.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 104.35% over the past year to $0.94, which beat the e...
YOKNEAM, Israel, Feb. 10, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its...
InMode's (INMD) Morpheus8 Platform and Morpheus8 Body that use RF fractional technology are expected to have contributed to the company's Q4 top line.
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
YOQNEAM, Israel, Jan. 6, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced it will present a corporate social responsibility (CSR) ...
InMode is an outperformer and leader in the growing medical aesthetic devices industry. Its products are made for a variety of purposes including liposuction, skin rejuvenation, cellulite treatment, and...
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Is (INMD) Outperforming Other Medical Stocks This Year?
InMode (INMD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Is (INMD) Outperforming Other Medical Stocks This Year?
InMode has seen a tough first and second quarter for obvious reasons, yet remained incredibly profitable. Net cash balances never put the viability of the company in doubt as valuations were far too low...
InMode Ltd. (INMD) CEO Moshe Mizrahy on Q3 2020 Results - Earnings Call Transcript
YOKNEAM, Israel, Nov. 12, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its...
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Catalyst Biosciences (CBIO), UFP Industries (UFPI), VeriSign (VRSN), InMode (INMD) and Castle Bi...
Technology won't always be on top. There's a bunch of budding industries that could prove to be winners over the next 5 years.
YOKNEAM, Israel, Nov. 2, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Mr. Moshe Mizrahy, Chairman and Chief Executi...
Find Strong Stocks with this New Analyst Coverage Screener
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like Perion (PERI), Live Oak (LOB), LexinFintech (LX) and InMode (INMD).
LAKE FOREST, Calif., Oct. 20, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to introduce to the market the Morpheus...
The cosmetic device maker's sales rebounded sharply in the third quarter.
These three health-related businesses are well positioned to provide market-beating gains.
InMode is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
The medical device maker announced a million-share repurchase program.
InMode went public in August, 2019, raising $70 million.
LAKE FOREST, Calif., Aug. 13, 2020 /PRNewswire/ -- InMode Ltd.
InMode Ltd. (INMD) CEO Moshe Mizrahy on Q2 2020 Results - Earnings Call Transcript
YOKNEAM, Israel, Aug. 5, 2020 /PRNewswire/ -- InMode Ltd.
YOKNEAM, Israel, Aug. 3, 2020 /PRNewswire/ -- InMode Ltd.
LAKE FOREST, Calif., July 27, 2020 /PRNewswire/ -- InMode Ltd.
InMode (INMD) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.
The medical device maker's boosting its second-quarter guidance.
InMode (INMD) closed the most recent trading day at $28.07, moving +0.36% from the previous trading session.
InMode (INMD) closed at $31.15 in the latest trading session, marking a +1.1% move from the prior day.
In the latest trading session, InMode (INMD) closed at $31.15, marking a -1.61% move from the previous day.
InMode: A Look Into The Fundamentals Reveals A Clear Undervaluation
InMode Ltd. (INMD) CEO Moshe Mizrahy on Q1 2020 Results - Earnings Call Transcript
About INMD
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of... [Read more...]
| Industry Medical Devices | IPO Date Aug 8, 2019 |
| Stock Exchange NASDAQ | Ticker Symbol INMD |
Financial Performance
In 2020, InMode's revenue was $206.11 million, an increase of 31.81% compared to the previous year's $156.36 million. Earnings were $75.03 million, an increase of 22.71%.
Analyst Forecasts
According to 3 analysts, the average rating for InMode stock is "Strong Buy." The 12-month stock price forecast is 99.67, which is an increase of 34.54% from the latest price.